Piramal
Also known as: LIFE MOLECULAR | Life Molecular Imaging GmbH | Nicholas Piramal Research Centre | PIRAMAL | Piramal Clinical Research (Hyderabad, India) | PIRAMAL CRITICAL | PIRAMAL ENT | Piramal Enterprises Limited | PIRAMAL HLTHCARE UK | Piramal Imaging GmbH | Piramal Imaging Limited | Piramal Imaging SA | Piramal Life Sciences | PIRAMAL PHARMA | Vice President- Clinical Research (R & D), Nicholas Piramal Research Centre | Wellquest Clinical Research
Highest phase reached
Phase 4
First clinical trial
May 1, 2005First marketed drug
Jul 29, 1994First NDA
Mar 19, 2014Last known activity
May 14, 2025
Timeline
1980s
- Jun 1, 1988
Piramal— Founded
1990s
- Jul 29, 1994
enflurane— Marketing Organization
2010s
- Nov 19, 2010
baclofen— NDA Secondary Org
- Mar 19, 2014
florbetaben F-18— NDA Organization
Drugs by trial phase (32 distinct, 52 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (5 own, 0 via acquisition)
Phase 1 (24 own, 0 via acquisition)
Indications
Approved for
Studied for
- Alzheimer Disease
- Amyloidosis
- Aneurysm
- Aortic Aneurysm
- Aortic Aneurysm, Abdominal
- Brain Neoplasms
- Breast Neoplasms
- Carcinoma
- Carcinoma, Squamous Cell
- Cognitive Dysfunction
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Down Syndrome
- Duodenal Ulcer
- Head and Neck Neoplasms
- Inflammation
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Lymphoma
- Lymphoma, Mantle-Cell
- Malnutrition
- Melanoma
- Mucositis
- Multiple Myeloma
- Neoplasms
- Neoplasms, Plasma Cell
- Overweight
- Pancreatic Neoplasms
- Prostatic Neoplasms
- Psoriasis
- Squamous Cell Carcinoma of Head and Neck
- Supranuclear Palsy, Progressive
- Syndrome
- Tauopathies
- Thrombosis
- Toothache
- Triple Negative Breast Neoplasms
- Venous Thrombosis
Marketed drugs (22)
Recent trials (50)
- NCT05184088Lead sponsorPhase 3Jan 31, 2023
- NCT05187546Lead sponsorPhase 1Mar 10, 2022
- NCT05143528CollaboratorPhase 3Feb 1, 2022
- NCT04715750Lead sponsorPhase 1Nov 12, 2020
- NCT04715750Study directorPhase 1Nov 12, 2020
- NCT02681172Lead sponsorPhase 4Oct 1, 2015
- NCT02483884Study directorPhase 1/Phase 2May 1, 2015
- NCT02483884Lead sponsorPhase 1/Phase 2May 1, 2015
- NCT02531360CollaboratorEarly Phase 1May 1, 2015
- NCT02370563Study directorPhase 1Nov 1, 2014
- NCT02370563Lead sponsorPhase 1Nov 1, 2014
- NCT02469376CollaboratorPhase 1Sep 1, 2014
- NCT02117336Lead sponsorPhase 1Jun 1, 2014
- NCT01910571Lead sponsorPhase 1Aug 1, 2013
- NCT01841463Lead sponsorPhase 1Aug 1, 2013
Details
- Founded
- Mumbai, IN Jun 1, 1988
- First NDA
- Mar 19, 2014
- Last known activity
- May 14, 2025